You are looking at all articles by M. Sreelata
Indian court’s Novartis ruling keeps door to cheap drugs open
After a lengthy court battle, India has rejected a major cancer drug patent bid — meaning lifesaving drugs will ...Lack of access to technology ‘hampers detection of substandard drugs’
Global drug markets are awash with low quality medicine, partly because of inadequate testing in poor countries, says a ...Crop yields stall in China, India
Crop yields of staples like rice, wheat, maize and soybean are stagnant in China and India.Committee advises halt to Indian Bt crop trials
An expert panel, appointed by the Supreme Court of India, has recommended a ten-year moratorium on all Bt food ...India tightens clinical trial regulations
India is planning tighter legislation to regulate clinical trials and expansion of its pool of experts in concerned medical ...M. Sreelata
Profile
Profile
A journalist in Delhi writing for Indian newspapers focusing on issues pertaining to health.
Contact Details: [email protected]
Location: Andhra Pradesh, India
Languages Spoken: Hindi, English
Areas of Interests: Agriculture, water, climate, health